SEQUENCE-SPECIFIC BINDING OF HUMAN ETS-1 TO THE T-CELL RECEPTOR ALPHA-GENE ENHANCER
SEQUENCE-SPECIFIC BINDING OF HUMAN ETS-1 TO THE T-CELL RECEPTOR ALPHA-GENE ENHANCER
复制标题
DOI:
10.1126/science.2237431
复制
发表时间:
1990-11-09
期刊:
影响因子:
56.9
通讯作者:
LEIDEN, JM
中科院分区:
文献类型:
--
作者:
HO, IC;BHAT, NK;LEIDEN, JM
Expression of the human T cell receptor (TCR) .alpha. gene is regulated by a T cell-specific transcriptional enhancer that is located 4.5 kilobases (kb) 3'' to the C.alpha.2, gene segement. The core enhancer contains two nuclear protein binding sites, T.alpha.1 and T.alpha.2, which are essential for full enhancer activity. T.alpha.1 contains a consensus cyclic adenosine monophosphate (cAMP) response element (CRE) and binds a set of ubiquitously expressed CRE binding proteins. In contrast, the transcription factors that interact with the T.alpha.2 site have not been defined. In this report, a .lambda.gt11 expression protocol was used to isolate a complementary DNA (cDNA) that programs the expression of a T.alpha.2 binding protein. DNA sequence analysis demonstrated that this clone encodes the human ets-1 proto-oncogene. Lysogen extracts produced with this cDNA clone contained a .beta.-galactosidase-Ets-1 fusion protein that bound specifically to a synthetic T.alpha.2 oligonucleotide. The Ets-1 binding site was localized to a 17-base pair (bp) region from the 3'' end of T.alpha.2. Mutation of five nucleotides within this sequence abolished both Ets-1 binding and the activity of the TCR .alpha. enhancer in T cells. These results demonstrate that Ets-1 binds in a sequence-specific fashion to the human TCR .alpha. enhancer and suggest that this developmentally regulated proto-oncogene functions in regulating TCR .alpha. gene expression.